Boothbay Fund Management »

Y Mabs Therapeutics shares owned by Boothbay Fund Management

Quarter-by-quarter ownership of Y Mabs Therapeutics (YMAB) shares owned by Boothbay Fund Management from 13F filings

Historical chart of Boothbay Fund Management investment in Y Mabs Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Y Mabs Therapeutics held by Boothbay Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Y Mabs Therapeutics by Boothbay Fund Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $7.3M 557k 13.15
2024-06-30 $4.5M 369k 12.08
2024-03-31 $5.6M 347k 16.26
2023-09-30 $85k 16k 5.45
2021-09-30 $219k 7.7k 28.51
2021-06-30 $268k 7.9k 33.77

More positions owned by Boothbay Fund Management

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Dell Technologies CL C Call Option (DELL)
Select Sector Spdr Tr Indl Put Option (XLI)
Cornerstone Strategic Value (CLM)
NVIDIA Corporation Put Option (NVDA)
Take-Two Interactive Software (TTWO)
Sba Communications Corp Cl A (SBAC)
Invesco Exch Traded Fd Tr Ii Sr Ln Etf (BKLN)
Netflix (NFLX)
Vertex Pharmaceuticals Incorporated Call Option (VRTX)
Elanco Animal Health Call Option (ELAN)
Amphenol Corp Cl A (APH)
Western Digital Call Option (WDC)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Equinix (EQIX)

View all positions for Boothbay Fund Management

Top funds holding Y Mabs Therapeutics

Paradigm Biocapital Advisors
BlackRock
Sofinnova Ventures
Vanguard Group
Polar Capital Holdings
Cormorant Asset Management
State Street Corporation
Caligan Partners
Geode Capital Management
Logos Global Management
D. E. Shaw & Co
Pictet Asset Management Holding SA
Boothbay Fund Management
Dimensional Fund Advisors
Soleus Capital Management

View all funds holding Y Mabs Therapeutics